drugset / Trial / NCT00392197
Study of Aripiprazole in Patients With Schizophrenia- Effects on Glucose Metabolism-
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The objective of this study is to examine the effects of aripiprazole on glucose metabolism in schizophrenic patients without hyperglycemia and diabetes mellitus or any history thereof.
Timeline
- Start
- 2006-11
- Primary completion
- 2010-03
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aripiprazole | Other / unclassified | 6 mg | Oral |
| Subject | Aripiprazole | Other / unclassified | 24 mg | Oral |